Once-daily Dosing of Ceftriaxone against Streptococcus pneumoniae Isolates in an In Vitro Pharmacodynamic Infection Model supplemented with Albumin.
	    		
		   		
	    	
    	
    	
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Ji An HUR
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Hye Sun CHUN
			        		
			        		;
		        		
		        		
		        		
			        		Sun Hee PARK
			        		
			        		;
		        		
		        		
		        		
			        		Su Mi CHOI
			        		
			        		;
		        		
		        		
		        		
			        		Sihyun KIM
			        		
			        		;
		        		
		        		
		        		
			        		Dong Gun LEE
			        		
			        		;
		        		
		        		
		        		
			        		Jung Hyun CHOI
			        		
			        		;
		        		
		        		
		        		
			        		Jin Hong YOO
			        		
			        		;
		        		
		        		
		        		
			        		Wan Shik SHIN
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. The Division of Infectious Diseases, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea. symonlee@catholic.ac.kr
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:In Vitro ; Original Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Ceftriaxone;
			        		
			        		
			        		
				        		Albumin;
			        		
			        		
			        		
				        		Resistance;
			        		
			        		
			        		
				        		Streptococcus pneumoniae
			        		
			        		
	        			
        			
        		
 
        	
            
            	- MeSH:
            	
	        			
	        				
	        				
				        		
					        		Ceftriaxone*;
				        		
			        		
				        		
					        		Homicide;
				        		
			        		
				        		
					        		Humans;
				        		
			        		
				        		
					        		Limit of Detection;
				        		
			        		
				        		
					        		Penicillins;
				        		
			        		
				        		
					        		Pneumonia;
				        		
			        		
				        		
					        		Streptococcus pneumoniae*;
				        		
			        		
				        		
					        		Streptococcus*
				        		
			        		
	        			
	        			
            	
            	
 
            
            
            	- From:
	            		
	            			Infection and Chemotherapy
	            		
	            		 2006;38(6):349-355
	            	
            	
 
            
            
            	- CountryRepublic of Korea
 
            
            
            	- Language:Korean
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	BACKGROUND: During the era of increasing penicillin resistant Streptococcus pneumoniae, it is important to have knowledge about adequate dosage and dosing interval of ceftriaxone (CTR). We examined efficacies of once-daily CTR and compared results in an in vitro pharmacodynamic infection model (IVPDIM) supplemented with albumin and those without albumin. METHODS: Using three clinically isolated S. pneumoniae that were susceptible (SM24), intermediate (SM47) and resistant (SM60) against CTR, we utilized a two-compartment IVPDIM. CTR 2 g was administered intravenously every 24 h. Human albumin was added with concentration of 4 g/dL. Samples were removed at multiple time points over a 48-h period to determine the colony counts. RESULTS: In SM24 and SM60, bactericidal effects were observed within 6 hours in groups without albumin. The number of colonies during 1st 6 hours were more decreased in albumin-free groups than in albumin-supplemented groups (P<0.05). In SM47, similar results were found during 1st 6 hours (P=0.03). But, regrowth was observed in albumin supplemented group at 30 h. Irrespective of results of minimal inhibitory concentrations and albumin supplementation, bactericidal effects were shown at 24 h in all 3 strains. All groups were decreased below the detection limit at 48 h. Development of resistance was not detected throughout the entire study period in either strain. CONCLUSIONS: Although extents of killing in albumin supplemented broth of once-daily CTR dosing were delayed in all 3 strains compared with those of albumin free broth, final efficacies were not different between the two groups.